In this study, we found that FT3 suppressed the negative association between BMI and serum osteocalcin levels, suggesting that the high FT3 within the reference range may alleviate the decline in serum osteocalcin levels in obesity. The gene discussed is BGLAP; the disease is obesity due to melanocortin 4 receptor deficiency.